Global Immunoassays
Market Report
2024
Immunoassays Market Report 2024 (Global Edition)
As per Cognative Market Research's latest report, The Global immunoassay market was valued at USD 34.29 billion in 2022 and will reach USD 51.44 billion by 2030, registering a CAGR of 5.2% for the forecast period 2023-2030.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
| Share your contact details to receive free updated sample copy/pages of the recently published edition of Immunoassays Market Report 2024.
Global Immunoassays Market Report 2024 Market Size Split by Product Type (Reagents & Kits, Analyzer/ instruments, Software, Services), by Application (Cardiology, Infectious diseases, Endocrinology, H...
As per Cognative Market Research's latest report, The Global immunoassay market was valued at USD 34.29 billion in 2022 and will reach USD 51.44 billion by 2030, registering a CAGR of 5.2% for the forecast period 2023-2030.
| Base Year | 2023 |
| Historical Data Time Period | 2019-2023 |
| Forecast Period | 2024-2031 |
| Global Immunoassays Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 5.2% |
| Market Split by Product Type |
|
| Market Split by Application |
|
| Market Split by Technology |
|
| Market Split by Specimen |
|
| Market Split by End User |
|
| List of Competitors |
|
| Regional Analysis |
|
Country Analysis |
|
Key Qualitative Information Covered |
|
Report scope is customizable as we have a huge database of Immunoassays industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Immunoassays Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Immunoassays Market Report Description
What is Immunoassays?
An immunoassay (IA) is a biochemical test that uses an antigen or an antibody to detect the presence or concentration of a macromolecule or a small molecule in a solution.
Immunoassays have been extensively employed in the drug research and pharmaceutical industries in many critical areas of pharmaceutical evaluation, such as illness diagnostics, therapeutic medication monitoring, and clinical pharmacology and biological equivalent investigations. Due to their natural accuracy, quickness, and high adaptability for the examination of a broad spectrum of analytical agents in biological materials, immunoassay techniques are crucial and popular in pharmaceutical analysis.
The diagnosis and treatment of diseases is one area where immunoassays are crucial. For instance, immunoassays are utilized in therapeutic medication monitoring, pregnancy tests, and cancer diagnostics. Immunoassays are essential instruments used in the development of biopharmaceutical products, such as vaccines, gene, and cell therapies. Immunoassay is frequently used in the research and manufacture of food to identify potentially harmful pollutants or allergens. For instance, immunoassay tests may be used to check for the presence of pathogens like E. coli, hazardous compounds, gluten, or heavy metal contamination. Immunoassays have more recently made their way into the environmental field. Utilizing immunoassay technology, pollutants in the environment can be found.
The increasing prevalence of infectious diseases, Technological advancement in immunoassay, and benefits offered by immunoassay are the major driving factors that fuel the immunoassay market.
Factors Affecting Immunoassays Market Growth
-
The increasing prevalence of infectious diseases:
Infectious diseases brought on by microorganisms like diphtheria, Ebola, flu, hepatitis, HIV/AIDS, human papillomavirus, tuberculosis, and outbreaks like dengue, Zika virus, Swine flu, and Covid-19 affect most of the population. Chronic diseases like cancer, diabetes, cardiovascular disorders, obesity, etc. also affect a large portion of the population. The primary approach for identifying viruses such as HIV, Epstein-Barr, dengue, hepatitis C, influenza, and the majority of other viruses is immunoassay. Through early diagnosis and treatment monitoring and modification based on diagnostic data, the immunoassay industry has a significant opportunity to hinder the route of rising illness rates. Immunoassays have benefits including straightforward methods, high accuracy, rapid results, effective, secure, secure, and are secure as well as environmentally friendly. Reagents are in high demand because they are affordable and do not need elaborate procedures.
-
Technological advancement in immunoassay:
The variety and scope of immunoassays' uses are growing phenomenally. To satisfy the demands of sensitivity, accuracy, and ease of use, a wide variety of various labels and test techniques have been developed. The sensitivity of immunoassay systems has significantly increased with the introduction of more sensitive labels and detection tools, enabling accurate measurement of a wider variety of analytes. Simultaneously, easy-to-use, affordable assay systems have been built that have the essential reliability, precision, and sensitivity to adapt immunoassay technology to a far wider range of applications including at-home testing, close patient monitoring, and extensive screening programs in developing nations. The creation of fusion antibody conjugates is now achievable because of recent advancements in molecular biology techniques, which may also transform the manufacturing of monoclonal antibodies by enhancing sensitivity and reducing the cost of reagents.
The launch of new products and the increasing interest of competitors in this industry is expected to boost the growth of the immunoassay market. For instance, in April 2022 Bio-Techne Corporation and Cygnus Technologies to detect process impurity on the Ella immunoassay platform launched the Simple Plex HEK 293 HCP 3 G assay. Impurity clearance is performed according to regulatory criteria to guarantee HCP and accurate quantification is required throughout the process phases.
Restraining factors for Immunoassays Market
-
Problems associated with immunoassay may hamper the market growth:
Interference in immunoassays is a major issue that has the potential to have negative clinical outcomes for patients. It can result in superfluous clinical inquiry as well as ineffective treatment. There is not a single method that can completely rule out interferences. It is crucial to be aware of the possibility of interference in immunoassays and to set up protocols to spot them wherever possible.
The high probability of producing false positives is a significant disadvantage of immunoassay. Along with these issues, there are others including antibody disorder, expensive media for cultures, expensive and time-consuming labor for antibody synthesis, inadequate sensitivity, and enzymes reducing activity after conjugation. This all issues hamper the demand and market growth of immunoassay.
Impact of COVID- 19 pandemic on the immunoassay market:
The COVID-19 pandemic urgently required increasing testing services, providing diagnoses, and implementing test-trace-isolate techniques essential to delivering proper care and halting the virus's transmission. There were nearly hundreds of new tests on the market, but there was scant to no independent data on how effectively they responded.
The COVID-19 pandemic's terrible effects remain evident across the world. This respiratory disease's high spreading makes it challenging for sophisticated viral diagnostic technology to offer quick, scalable, inexpensive, and accurate tests. While molecular testing has been the preferred method for precisely identifying viral RNA in suspect patients, immunoassays were used to monitor people by detecting antibodies against SARS-CoV-2. Immunoassays are indirect techniques of detecting viral infection than molecular testing. As a result, the COVID-19 pandemic had a favorable effect on the immunoassay market.
We have various report editions of Immunoassays Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Immunoassays Industry News
- February 2023, Charles River Laboratories International, Inc. announced the launch of its first Enzyme-Linked Immunosorbent Assay (ELISA) Kit
The first Enzyme-Linked Immunosorbent Assay (ELISA) Kit from Charles River Laboratories International, Inc. has been made available for identifying and measuring residual host cell proteins (HCP) in CHO-based biotherapeutics. The HCP ELISA kit from Charles River reaches rates for sensitivity and specificity that are among the highest in the industry, at 0.1 ng/mL and 90% antibody coverage, respectively. The different chicken immunoglobulin Y (IgY) antibodies used can be credited with this increase in sensitivity and specificity.
- April 2022, American Laboratory Products Company (ALPO) Merged with GeneProof
American Laboratory Products Company, Ltd. ("ALPCO") is a renowned molecular diagnostics firm headquartered in Brno, Czech Republic, and GeneProof a.s. ("GeneProof") have announced a merger. In their respective areas, ALPCO and GeneProof have both established strong reputations: ALPCO in the field of immunodiagnostics and GeneProof in the field of molecular diagnostics.
- January 2022, Hycor Biomedical Received FDA 510(k) Clearance for the NOVEOS Specific IgE test
An in vitro quantitative test for the detection of allergen-specific IgE in human serum is the NOVEOS Specific IgE test. The NOVEOS Immunoassay Analyzer must be used with the NOVEOS Specific IgE Assay. It is meant to be used in clinical laboratories as an in vitro diagnostic assistance in the clinical diagnosis of IgE-mediated allergy diseases in conjunction with other clinical findings.
- February 2021, Agilent Technologies Inc. introduced Agilent Dako SARS-CoV-2 IgG enzyme-linked immunosorbent assay
Agilent Technologies Inc. introduced the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit. It is intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma. The kit has successfully undergone FDA notification in compliance with Section IV.D of the FDA's "Policy for Coronavirus Disease-2019 Tests during the Public Health Emergency (Revised)". This marks Agilent's entry into SARS-CoV-2 testing in the US.
- January 2021, Abbott received the CE Mark for its Panbio COVID-19 Ag Rapid Test Device
Abbott announced it has received CE Mark for two new uses of its Panbio COVID-19 Ag Rapid Test Device for the detection of the SARS-CoV-2 virus such as asymptomatic testing and self-swabbing. By allowing patients to maintain distance during the testing process, self-swabbing with a patient-friendly nose swab enhances patient comfort and lowers the possibility of healthcare staff unintentionally contracting the virus.
Top Companies Market Share in Immunoassays Industry: (In no particular order of Rank)
- Abbott Laboratories
- Roche
- Thermo Fisher Scientific
- Siemens Healthineers
- Bio-Rad Laboratories
- Ortho Clinical Diagnostics
- Sysmex Corporation
- BioMerieux SA
- Randox Laboratories
- Tosoh
- Quidel
- Beckman Coulter
- Becton Dickinson and Company
- F. Hoffmann-La Roche AG
- Qiagen
- Luminex Corporation
- DiaSorin
- Radiometer
- IDEXX Laboratories
- Siemens
- Fujirebio
- Autobio Diagnostics Co
- BioLegend
- Guangzhou Wondfo Biotech
- Inova Diagnostics Inc.
- ELISA
- Danaher Corporation (Beckman Coulter)
- Confidential Data
- Access The Paid Version
- Data Hidden
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
North America held the largest revenue market share over the other regions in the global immunoassay market:
The expansion of the market in the region is being driven by increasing demand for immunoassays because of rising per capita health expenditures, improvements in healthcare infrastructure, and an increase in the prevalence of infectious diseases and cancer cases in the United States. For instance, the American Cancer Society (ACS) 'Cancer Facts & Figures 2023', estimates that 1,958,310 new instances of cancer will be reported in the United States in 2023, caused by smoking, carrying too much body weight, consuming alcohol, eating poorly, and engaging in insufficient physical exercise. Due to the rising incidence of cancer in the United States, The usage of immunoassays for cancer diagnosis is predicted to increase.
Because of the rising use of medical technologies, rising rates of the incidence of chronic diseases, infectious diseases, and geriatric populations, and significant spending on R&D by pharmaceutical companies and government agencies for disorders and diseases including diabetes and chronic illnesses is one of the main drivers of the regional market.
The current report Scope analyzes Immunoassays Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
- North America (United States, Canada, Mexico)
- Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
- Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
- South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
- Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Immunoassays Market Share (%) by Region (2019-2031)
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Immunoassays Market Analysis
Global Immunoassays Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Immunoassays Industry growth. Immunoassays market has been segmented with the help of its Product Type, Application Technology, and others. Immunoassays market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
By product, reagents and kits accounted largest revenue share in the global immunoassay market
The immunoassay market is segmented into reagents & kits, analyzers, software, and services, in which reagents and kits hold the largest share of the immunoassay market.
Solutions, buffers, reagents, and kits used in immunoassays are used to identify and measure biological targets in serum, plasma, cell culture media, and other samples. Immunoassay kits come in various forms utilized in laboratories, clinical settings, and industry. The basis of immunoassay kits is the ability of an antibody to attach to and recognize a particular macromolecule, usually a protein, and produce a quantifiable signal in response to the binding. To determine the number of proteins present in biological samples like urine, serum, or cell extracts, assay kits are frequently employed. The assays could be presented in colorimetric, fluorescent, or chemiluminescent formats.
Immunoassay reagents include antibodies, labels that produce signals, and separation matrices. The essential components necessary for any immunoassay are antibodies. There are two types of antibodies: polyclonal and monoclonal. However, monoclonal antibodies are preferable to polyclonal ones for the production of immunoassays for pharmaceutical analysis applications. This is explained by their greater degree of specificity and affinity for the analyte. Therefore increasing the use of reagents and kits in immunoassay can drive the market. In addition, the approval and launch of novel immunoassay kits are expected to support segment growth.
- Reagents & Kits
- Analyzer/ instruments
- Software
- Services
Immunoassays Market Share (%) by Product Type in 2019-2031
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Immunoassays Industry. Request a Free Sample PDF!
Application Segment Analysis of Immunoassays Market
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities for each application of Immunoassays from 2019 to 2031. This will also help to analyze the demand for Immunoassays across different end-use industries. Our research team will also help acquire additional data such as Value Chain, Patent analysis, Company Evaluation Quadrant (Matrix), and much more confidential analysis and data insights.
Some of the key Application of Immunoassays are:
- Cardiology
- Infectious diseases
- Endocrinology
- Hematology
- Oncology
- Toxicology
- Bone And Mineral Disorders
- Blood Screening
- Autoimmune Disorders
- Allergy Diagnostics
- Newborn Screening
Immunoassays Market Share (%) by Application in 2019-2031
2019
2023
2031
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Immunoassays Technology Segment Analysis
By Technology, Enzyme-linked immunosorbent assay (ELSA) dominated the worldwide medical robots market revenue share.
The immunoassay market is segmented into Enzyme-Linked Immunosorbent Assay (ELISA), chemiluminescence immunoassay, rapid tests, Enzyme-Linked Fluorescent Assay (ELFA), ELISpot, western blotting, and a radioimmunoassay; in which Enzyme-Linked Immunosorbent Assay (ELISA) hold the largest share of the immunoassay market.
The analytical biochemistry technique known as the enzyme-linked immunosorbent assay (ELISA) is frequently employed. The assay uses a solid-phase form of enzyme immunoassay (EIA), utilizing antibodies against the target protein to find the presence of a ligand (frequently a protein) in a sample of liquid. In addition to being utilized as quality assurance in numerous industries, ELISA has been applied as a diagnostic tool across biotechnology, plant pathology, and medicine.
The ELISA is a helpful technique for figuring out serum antibody concentrations since it may be used to assess either the amount of antigen or the availability of antibodies in a sample (as with the HIV test or West Nile virus). As a serological blood test for celiac disease, it additionally has found use in the food business for identifying probable food allergens such as milk, peanuts, walnuts, almonds, and eggs. Additionally, ELISA can be utilized in toxicology to provide a quick presumptive screening method for specific drug classes. Numerous infections, including dengue, malaria, Chagas disease, and others, can be detected using ELISA tests. In vitro diagnostics using ELISA assays is also widely used in medical labs. Therefore, increasing demand for ELISA in various pharmaceutical activities boosts the market.
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chemiluminescence immunoassay
- Rapid Tests
- Enzyme-Linked Fluorescent Assay (ELFA)
- ELISpot
- Western Blotting
- Radioimmunoassay
Immunoassays Specimen Segment Analysis
- Blood
- Saliva
- Urine
- Other
Immunoassays End User Segment Analysis
- Hospitals
- Clinics
- Laboratories
- Pharmaceutical and Biotechnology Companies
- Blood Banks
- Academics Research Centers
Author's Detail
Anushka GoreResearch Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Author's Conclusion
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Immunoassays Market is witnessing significant growth in the near future.
In 2023, the Reagents & Kits segment accounted for noticeable share of global Immunoassays Market and is projected to experience significant growth in the near future.
The Cardiology segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Abbott Laboratories , Thermo Fisher Scientific and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Frequently Asked Questions (FAQs)
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Latest News about Immunoassays Market
Sources from Medical Devices & Consumables Industry
- http://www.trade.gov
- http://www.gov.uk
- http://www.fda.gov
- http://www.hhs.gov
- http://www.who.int
- http://www.bls.gov
- http://www.gao.gov
- http://www.ncbi.nlm.nih.gov
- http://www.healthcaredive.com
- http://www.weforum.org
- http://www.health.gov.za
- http://www.usaid.gov
- http://www.eumdr.com
- http://www.cdc.gov
- http://www.ama-assn.org
- http://www.washingtonpost.com
- http://www.ecfr.gov
- http://www.hbr.org
- http://www.worldbank.org
- http://www.commission.europa.eu
- http://www.cbi.eu
- http://www.unicef.org
- http://www.ecipe.org
- http://www.ema.europa.eu
Immunoassays Market Report Table of Content
Disclaimer:
- This is just a redacted sample pages of the actual deliverable report and only for representative purposes
- Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
- The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
- Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
- If applicable; On Request Volume Data will also be provided (at an Additional Cost).
| Product Type | Reagents & Kits, Analyzer/ instruments, Software, Services |
| Application | Cardiology, Infectious diseases, Endocrinology, Hematology, Oncology, Toxicology, Bone And Mineral Disorders, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Newborn Screening |
| Technology | Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence immunoassay, Rapid Tests, Enzyme-Linked Fluorescent Assay (ELFA), ELISpot, Western Blotting, Radioimmunoassay |
| Specimen | Blood, Saliva, Urine, Other |
| End User | Hospitals, Clinics, Laboratories, Pharmaceutical and Biotechnology Companies, Blood Banks, Academics Research Centers |
| List of Competitors | Abbott Laboratories, Roche, Thermo Fisher Scientific, Siemens Healthineers, Bio-Rad Laboratories, Ortho Clinical Diagnostics, Sysmex Corporation, BioMerieux SA, Randox Laboratories, Tosoh, Quidel, Beckman Coulter, Becton Dickinson and Company, F. Hoffmann-La Roche AG, Qiagen, Luminex Corporation, DiaSorin, Radiometer, IDEXX Laboratories, Siemens, Fujirebio, Autobio Diagnostics Co, BioLegend, Guangzhou Wondfo Biotech, Inova Diagnostics Inc., ELISA, Danaher Corporation (Beckman Coulter) |
This chapter will help you gain GLOBAL Market Analysis of Immunoassays. Further deep in this chapter, you will be able to review Global Immunoassays Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
-
1.1 Global Immunoassays Market Size, Trend Analysis 2019 - 2031
-
1.2 Global Immunoassays Market Size By Regions 2019 - 2031
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
-
1.2.1 Global Immunoassays Revenue Market Size By Region
-
-
1.3 Global Immunoassays Market Size By Product Type 2019 -2031
-
1.3.1 Reagents & Kits Market Size
-
1.3.2 Analyzer/ instruments Market Size
-
1.3.3 Software Market Size
-
1.3.4 Services Market Size
-
-
1.4 Global Immunoassays Market Size By Application 2019 -2031
-
1.4.1 Cardiology Market Size
-
1.4.2 Infectious diseases Market Size
-
1.4.3 Endocrinology Market Size
-
1.4.4 Hematology Market Size
-
1.4.5 Oncology Market Size
-
1.4.6 Toxicology Market Size
-
1.4.7 Bone And Mineral Disorders Market Size
-
1.4.8 Blood Screening Market Size
-
1.4.9 Autoimmune Disorders Market Size
-
1.4.10 Allergy Diagnostics Market Size
-
1.4.11 Newborn Screening Market Size
-
-
1.5 Global Immunoassays Market Size By Technology 2019 -2031
-
1.5.1 Enzyme-Linked Immunosorbent Assay (ELISA) Market Size
-
1.5.2 Chemiluminescence immunoassay Market Size
-
1.5.3 Rapid Tests Market Size
-
1.5.4 Enzyme-Linked Fluorescent Assay (ELFA) Market Size
-
1.5.5 ELISpot Market Size
-
1.5.6 Western Blotting Market Size
-
1.5.7 Radioimmunoassay Market Size
-
-
1.6 Global Immunoassays Market Size By Specimen for 2019 -2031
-
1.6.1 Blood Market Size
-
1.6.2 Saliva Market Size
-
1.6.3 Urine Market Size
-
1.6.4 Other Market Size
-
-
1.7 Global Immunoassays Market Size By End User for 2019 -2031
-
1.7.1 Hospitals Market Size
-
1.7.2 Clinics Market Size
-
1.7.3 Laboratories Market Size
-
1.7.4 Pharmaceutical and Biotechnology Companies Market Size
-
1.7.5 Blood Banks Market Size
-
1.7.6 Academics Research Centers Market Size
-
-
1.8 Global Level Competitor Analysis (Subject to Data Availability (Private Players))
-
1.9 Executive Summary Global Market (2019 vs 2024 vs 2031)
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
-
1.9.1 Regional Market Revenue Summary 2019 vs 2024 vs 2031
-
1.9.2 Global Market Revenue Split By Product Type
-
1.9.3 Global Market Revenue Split By Application
-
1.9.4 Global Market Revenue Split By Technology
-
1.9.5 Global Market Revenue Split By Specimen
-
1.9.6 Global Market Revenue Split By End User
-
1.9.7 Global Market Dynamics, Trends, Drivers, Restraints, Opportunities
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
-
Chapter 2 North America Market Analysis
-
2.1 North America Immunoassays Market Size 2019 - 2031
-
2.1.1 North America Immunoassays Market Size By Country 2019 - 2031
-
2.1.2 North America Immunoassays Market Size by Product Type 2019 -2031
-
2.1.2.1 North America Reagents & Kits Market Size
-
2.1.2.2 North America Analyzer/ instruments Market Size
-
2.1.2.3 North America Software Market Size
-
2.1.2.4 North America Services Market Size
-
-
2.1.3 North America Immunoassays Market Size by Application 2019 -2031
-
2.1.3.1 North America Cardiology Market Size
-
2.1.3.2 North America Infectious diseases Market Size
-
2.1.3.3 North America Endocrinology Market Size
-
2.1.3.4 North America Hematology Market Size
-
2.1.3.5 North America Oncology Market Size
-
2.1.3.6 North America Toxicology Market Size
-
2.1.3.7 North America Bone And Mineral Disorders Market Size
-
2.1.3.8 North America Blood Screening Market Size
-
2.1.3.9 North America Autoimmune Disorders Market Size
-
2.1.3.10 North America Allergy Diagnostics Market Size
-
2.1.3.11 North America Newborn Screening Market Size
-
-
2.1.4 North America Immunoassays Market Size by Technology 2019 -2031
-
2.1.4.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size
-
2.1.4.2 North America Chemiluminescence immunoassay Market Size
-
2.1.4.3 North America Rapid Tests Market Size
-
2.1.4.4 North America Enzyme-Linked Fluorescent Assay (ELFA) Market Size
-
2.1.4.5 North America ELISpot Market Size
-
2.1.4.6 North America Western Blotting Market Size
-
2.1.4.7 North America Radioimmunoassay Market Size
-
-
2.1.5 North America Immunoassays Market Size by Specimen 2019 -2031
-
2.1.5.1 North America Blood Market Size
-
2.1.5.2 North America Saliva Market Size
-
2.1.5.3 North America Urine Market Size
-
2.1.5.4 North America Other Market Size
-
-
2.1.6 North America Immunoassays Market Size by End User 2019 -2031
-
2.1.6.1 North America Hospitals Market Size
-
2.1.6.2 North America Clinics Market Size
-
2.1.6.3 North America Laboratories Market Size
-
2.1.6.4 North America Pharmaceutical and Biotechnology Companies Market Size
-
2.1.6.5 North America Blood Banks Market Size
-
2.1.6.6 North America Academics Research Centers Market Size
-
-
Chapter 3 Europe Market Analysis
-
3.1 Europe Immunoassays Market Size 2019 - 2031
-
3.1.1 Europe Immunoassays Market Size By Country 2019 - 2031
-
3.1.2 Europe Immunoassays Market Size by Product Type 2019 -2031
-
3.1.2.1 Europe Reagents & Kits Market Size
-
3.1.2.2 Europe Analyzer/ instruments Market Size
-
3.1.2.3 Europe Software Market Size
-
3.1.2.4 Europe Services Market Size
-
-
3.1.3 Europe Immunoassays Market Size by Application 2019 -2031
-
3.1.3.1 Europe Cardiology Market Size
-
3.1.3.2 Europe Infectious diseases Market Size
-
3.1.3.3 Europe Endocrinology Market Size
-
3.1.3.4 Europe Hematology Market Size
-
3.1.3.5 Europe Oncology Market Size
-
3.1.3.6 Europe Toxicology Market Size
-
3.1.3.7 Europe Bone And Mineral Disorders Market Size
-
3.1.3.8 Europe Blood Screening Market Size
-
3.1.3.9 Europe Autoimmune Disorders Market Size
-
3.1.3.10 Europe Allergy Diagnostics Market Size
-
3.1.3.11 Europe Newborn Screening Market Size
-
-
3.1.4 Europe Immunoassays Market Size by Technology 2019 -2031
-
3.1.4.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size
-
3.1.4.2 Europe Chemiluminescence immunoassay Market Size
-
3.1.4.3 Europe Rapid Tests Market Size
-
3.1.4.4 Europe Enzyme-Linked Fluorescent Assay (ELFA) Market Size
-
3.1.4.5 Europe ELISpot Market Size
-
3.1.4.6 Europe Western Blotting Market Size
-
3.1.4.7 Europe Radioimmunoassay Market Size
-
-
3.1.5 Europe Immunoassays Market Size by Specimen 2019 -2031
-
3.1.5.1 Europe Blood Market Size
-
3.1.5.2 Europe Saliva Market Size
-
3.1.5.3 Europe Urine Market Size
-
3.1.5.4 Europe Other Market Size
-
-
3.1.6 Europe Immunoassays Market Size by End User 2019 -2031
-
3.1.6.1 Europe Hospitals Market Size
-
3.1.6.2 Europe Clinics Market Size
-
3.1.6.3 Europe Laboratories Market Size
-
3.1.6.4 Europe Pharmaceutical and Biotechnology Companies Market Size
-
3.1.6.5 Europe Blood Banks Market Size
-
3.1.6.6 Europe Academics Research Centers Market Size
-
-
Chapter 4 Asia Pacific Market Analysis
-
4.1 Asia Pacific Immunoassays Market Size 2019 - 2031
-
4.1.1 Asia Pacific Immunoassays Market Size By Country 2019 - 2031
-
4.1.2 Asia Pacific Immunoassays Market Size by Product Type 2019 -2031
-
4.1.2.1 Asia Pacific Reagents & Kits Market Size
-
4.1.2.2 Asia Pacific Analyzer/ instruments Market Size
-
4.1.2.3 Asia Pacific Software Market Size
-
4.1.2.4 Asia Pacific Services Market Size
-
-
4.1.3 Asia Pacific Immunoassays Market Size by Application 2019 -2031
-
4.1.3.1 Asia Pacific Cardiology Market Size
-
4.1.3.2 Asia Pacific Infectious diseases Market Size
-
4.1.3.3 Asia Pacific Endocrinology Market Size
-
4.1.3.4 Asia Pacific Hematology Market Size
-
4.1.3.5 Asia Pacific Oncology Market Size
-
4.1.3.6 Asia Pacific Toxicology Market Size
-
4.1.3.7 Asia Pacific Bone And Mineral Disorders Market Size
-
4.1.3.8 Asia Pacific Blood Screening Market Size
-
4.1.3.9 Asia Pacific Autoimmune Disorders Market Size
-
4.1.3.10 Asia Pacific Allergy Diagnostics Market Size
-
4.1.3.11 Asia Pacific Newborn Screening Market Size
-
-
4.1.4 Asia Pacific Immunoassays Market Size by Technology 2019 -2031
-
4.1.4.1 Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size
-
4.1.4.2 Asia Pacific Chemiluminescence immunoassay Market Size
-
4.1.4.3 Asia Pacific Rapid Tests Market Size
-
4.1.4.4 Asia Pacific Enzyme-Linked Fluorescent Assay (ELFA) Market Size
-
4.1.4.5 Asia Pacific ELISpot Market Size
-
4.1.4.6 Asia Pacific Western Blotting Market Size
-
4.1.4.7 Asia Pacific Radioimmunoassay Market Size
-
-
4.1.5 Asia Pacific Immunoassays Market Size by Specimen 2019 -2031
-
4.1.5.1 Asia Pacific Blood Market Size
-
4.1.5.2 Asia Pacific Saliva Market Size
-
4.1.5.3 Asia Pacific Urine Market Size
-
4.1.5.4 Asia Pacific Other Market Size
-
-
4.1.6 Asia Pacific Immunoassays Market Size by End User 2019 -2031
-
4.1.6.1 Asia Pacific Hospitals Market Size
-
4.1.6.2 Asia Pacific Clinics Market Size
-
4.1.6.3 Asia Pacific Laboratories Market Size
-
4.1.6.4 Asia Pacific Pharmaceutical and Biotechnology Companies Market Size
-
4.1.6.5 Asia Pacific Blood Banks Market Size
-
4.1.6.6 Asia Pacific Academics Research Centers Market Size
-
-
Chapter 5 South America Market Analysis
-
5.1 South America Immunoassays Market Size 2019 - 2031
-
5.1.1 South America Immunoassays Market Size By Country 2019 - 2031
-
5.1.2 South America Immunoassays Market Size by Product Type 2019 -2031
-
5.1.2.1 South America Reagents & Kits Market Size
-
5.1.2.2 South America Analyzer/ instruments Market Size
-
5.1.2.3 South America Software Market Size
-
5.1.2.4 South America Services Market Size
-
-
5.1.3 South America Immunoassays Market Size by Application 2019 -2031
-
5.1.3.1 South America Cardiology Market Size
-
5.1.3.2 South America Infectious diseases Market Size
-
5.1.3.3 South America Endocrinology Market Size
-
5.1.3.4 South America Hematology Market Size
-
5.1.3.5 South America Oncology Market Size
-
5.1.3.6 South America Toxicology Market Size
-
5.1.3.7 South America Bone And Mineral Disorders Market Size
-
5.1.3.8 South America Blood Screening Market Size
-
5.1.3.9 South America Autoimmune Disorders Market Size
-
5.1.3.10 South America Allergy Diagnostics Market Size
-
5.1.3.11 South America Newborn Screening Market Size
-
-
5.1.4 South America Immunoassays Market Size by Technology 2019 -2031
-
5.1.4.1 South America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size
-
5.1.4.2 South America Chemiluminescence immunoassay Market Size
-
5.1.4.3 South America Rapid Tests Market Size
-
5.1.4.4 South America Enzyme-Linked Fluorescent Assay (ELFA) Market Size
-
5.1.4.5 South America ELISpot Market Size
-
5.1.4.6 South America Western Blotting Market Size
-
5.1.4.7 South America Radioimmunoassay Market Size
-
-
5.1.5 South America Immunoassays Market Size by Specimen 2019 -2031
-
5.1.5.1 South America Blood Market Size
-
5.1.5.2 South America Saliva Market Size
-
5.1.5.3 South America Urine Market Size
-
5.1.5.4 South America Other Market Size
-
-
5.1.6 South America Immunoassays Market Size by End User 2019 -2031
-
5.1.6.1 South America Hospitals Market Size
-
5.1.6.2 South America Clinics Market Size
-
5.1.6.3 South America Laboratories Market Size
-
5.1.6.4 South America Pharmaceutical and Biotechnology Companies Market Size
-
5.1.6.5 South America Blood Banks Market Size
-
5.1.6.6 South America Academics Research Centers Market Size
-
-
Chapter 6 Middle East and Africa Market Analysis
-
6.1 Middle East and Africa Immunoassays Market Size 2019 - 2031
-
6.1.1 Middle East and Africa Immunoassays Market Size By Country 2019 - 2031
-
6.1.2 Middle East and Africa Immunoassays Market Size by Product Type 2019 -2031
-
6.1.2.1 Middle East and Africa Reagents & Kits Market Size
-
6.1.2.2 Middle East and Africa Analyzer/ instruments Market Size
-
6.1.2.3 Middle East and Africa Software Market Size
-
6.1.2.4 Middle East and Africa Services Market Size
-
-
6.1.3 Middle East and Africa Immunoassays Market Size by Application 2019 -2031
-
6.1.3.1 Middle East and Africa Cardiology Market Size
-
6.1.3.2 Middle East and Africa Infectious diseases Market Size
-
6.1.3.3 Middle East and Africa Endocrinology Market Size
-
6.1.3.4 Middle East and Africa Hematology Market Size
-
6.1.3.5 Middle East and Africa Oncology Market Size
-
6.1.3.6 Middle East and Africa Toxicology Market Size
-
6.1.3.7 Middle East and Africa Bone And Mineral Disorders Market Size
-
6.1.3.8 Middle East and Africa Blood Screening Market Size
-
6.1.3.9 Middle East and Africa Autoimmune Disorders Market Size
-
6.1.3.10 Middle East and Africa Allergy Diagnostics Market Size
-
6.1.3.11 Middle East and Africa Newborn Screening Market Size
-
-
6.1.4 Middle East and Africa Immunoassays Market Size by Technology 2019 -2031
-
6.1.4.1 Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size
-
6.1.4.2 Middle East and Africa Chemiluminescence immunoassay Market Size
-
6.1.4.3 Middle East and Africa Rapid Tests Market Size
-
6.1.4.4 Middle East and Africa Enzyme-Linked Fluorescent Assay (ELFA) Market Size
-
6.1.4.5 Middle East and Africa ELISpot Market Size
-
6.1.4.6 Middle East and Africa Western Blotting Market Size
-
6.1.4.7 Middle East and Africa Radioimmunoassay Market Size
-
-
6.1.5 Middle East and Africa Immunoassays Market Size by Specimen 2019 -2031
-
6.1.5.1 Middle East and Africa Blood Market Size
-
6.1.5.2 Middle East and Africa Saliva Market Size
-
6.1.5.3 Middle East and Africa Urine Market Size
-
6.1.5.4 Middle East and Africa Other Market Size
-
-
6.1.6 Middle East and Africa Immunoassays Market Size by End User 2019 -2031
-
6.1.6.1 Middle East and Africa Hospitals Market Size
-
6.1.6.2 Middle East and Africa Clinics Market Size
-
6.1.6.3 Middle East and Africa Laboratories Market Size
-
6.1.6.4 Middle East and Africa Pharmaceutical and Biotechnology Companies Market Size
-
6.1.6.5 Middle East and Africa Blood Banks Market Size
-
6.1.6.6 Middle East and Africa Academics Research Centers Market Size
-
-
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
-
7.1 Country 1 Market Analysis
-
7.1.1 Country 1Immunoassays Market Size by Product Type 2019 -2031
-
7.1.2 Country 1Immunoassays Market Size by Application 2019 -2031
-
7.1.3 Country 1Immunoassays Market Size by Technology 2019 -2031
-
7.1.4 Country 1Immunoassays Market Size by Specimen 2019 -2031
-
7.1.5 Country 1Immunoassays Market Size by End User 2019 -2031
-
-
7.2 Country 2 Market Analysis
-
7.2.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.3 Country 3 Market Analysis
-
7.3.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.4 Country 4 Market Analysis
-
7.4.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.5 Country 5 Market Analysis
-
7.5.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.6 Country 6 Market Analysis
-
7.6.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.7 Country 7 Market Analysis
-
7.7.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.8 Country 8 Market Analysis
-
7.8.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.9 Country 9 Market Analysis
-
7.9.1 Segmentation Analysis will be provided as shown for Country 1
-
-
7.10 Country 10 Market Analysis
-
7.10.1 Segmentation Analysis will be provided as shown for Country 1
-
Competitor's Market Share and Revenue (Subject to Data Availability for Private Players)
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
-
8.1 Top Competitors Analysis
-
8.1.1 Top Players Ranking 2022
-
8.1.2 Global Immunoassays Market Revenue and Share by Manufacturers (2019-2023)
(Subject to Data Availability (Private Players))
-
8.1.3 Industry Mergers and Acquisition Analysis
-
8.1.4 New Product Launch Analysis
-
-
8.2 Company Profile (Data Subject to Availability)
-
8.2.1 Abbott Laboratories
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.1.2 Business Overview
-
8.2.1.3 Financials (Subject to data availability)
-
8.2.1.4 Product Types Specification
-
8.2.1.5 Business Strategy
-
8.2.1.6 S.W.O.TAnalysis
-
-
8.2.2 Roche
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.2.2 Business Overview
-
8.2.2.3 Financials (Subject to data availability)
-
8.2.2.4 Product Types Specification
-
8.2.2.5 Business Strategy
-
8.2.2.6 S.W.O.TAnalysis
-
-
8.2.3 Thermo Fisher Scientific
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.3.2 Business Overview
-
8.2.3.3 Financials (Subject to data availability)
-
8.2.3.4 Product Types Specification
-
8.2.3.5 Business Strategy
-
8.2.3.6 S.W.O.TAnalysis
-
-
8.2.4 Siemens Healthineers
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.4.2 Business Overview
-
8.2.4.3 Financials (Subject to data availability)
-
8.2.4.4 Product Types Specification
-
8.2.4.5 Business Strategy
-
8.2.4.6 S.W.O.TAnalysis
-
-
8.2.5 Bio-Rad Laboratories
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.5.2 Business Overview
-
8.2.5.3 Financials (Subject to data availability)
-
8.2.5.4 Product Types Specification
-
8.2.5.5 Business Strategy
-
8.2.5.6 S.W.O.TAnalysis
-
-
8.2.6 Ortho Clinical Diagnostics
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.6.2 Business Overview
-
8.2.6.3 Financials (Subject to data availability)
-
8.2.6.4 Product Types Specification
-
8.2.6.5 Business Strategy
-
8.2.6.6 S.W.O.TAnalysis
-
-
8.2.7 Sysmex Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.7.2 Business Overview
-
8.2.7.3 Financials (Subject to data availability)
-
8.2.7.4 Product Types Specification
-
8.2.7.5 Business Strategy
-
8.2.7.6 S.W.O.TAnalysis
-
-
8.2.8 BioMerieux SA
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.8.2 Business Overview
-
8.2.8.3 Financials (Subject to data availability)
-
8.2.8.4 Product Types Specification
-
8.2.8.5 Business Strategy
-
8.2.8.6 S.W.O.TAnalysis
-
-
8.2.9 Randox Laboratories
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.9.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.9.2 Business Overview
-
8.2.9.3 Financials (Subject to data availability)
-
8.2.9.4 Product Types Specification
-
8.2.9.5 Business Strategy
-
8.2.9.6 S.W.O.TAnalysis
-
-
8.2.10 Tosoh
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.10.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.10.2 Business Overview
-
8.2.10.3 Financials (Subject to data availability)
-
8.2.10.4 Product Types Specification
-
8.2.10.5 Business Strategy
-
8.2.10.6 S.W.O.TAnalysis
-
-
8.2.11 Quidel
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.11.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.11.2 Business Overview
-
8.2.11.3 Financials (Subject to data availability)
-
8.2.11.4 Product Types Specification
-
8.2.11.5 Business Strategy
-
8.2.11.6 S.W.O.TAnalysis
-
-
8.2.12 Beckman Coulter
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.12.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.12.2 Business Overview
-
8.2.12.3 Financials (Subject to data availability)
-
8.2.12.4 Product Types Specification
-
8.2.12.5 Business Strategy
-
8.2.12.6 S.W.O.TAnalysis
-
-
8.2.13 Becton Dickinson and Company
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.13.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.13.2 Business Overview
-
8.2.13.3 Financials (Subject to data availability)
-
8.2.13.4 Product Types Specification
-
8.2.13.5 Business Strategy
-
8.2.13.6 S.W.O.TAnalysis
-
-
8.2.14 F. Hoffmann-La Roche AG
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.14.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.14.2 Business Overview
-
8.2.14.3 Financials (Subject to data availability)
-
8.2.14.4 Product Types Specification
-
8.2.14.5 Business Strategy
-
8.2.14.6 S.W.O.TAnalysis
-
-
8.2.15 Qiagen
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.15.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.15.2 Business Overview
-
8.2.15.3 Financials (Subject to data availability)
-
8.2.15.4 Product Types Specification
-
8.2.15.5 Business Strategy
-
8.2.15.6 S.W.O.TAnalysis
-
-
8.2.16 Luminex Corporation
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.16.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.16.2 Business Overview
-
8.2.16.3 Financials (Subject to data availability)
-
8.2.16.4 Product Types Specification
-
8.2.16.5 Business Strategy
-
8.2.16.6 S.W.O.TAnalysis
-
-
8.2.17 DiaSorin
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.17.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.17.2 Business Overview
-
8.2.17.3 Financials (Subject to data availability)
-
8.2.17.4 Product Types Specification
-
8.2.17.5 Business Strategy
-
8.2.17.6 S.W.O.TAnalysis
-
-
8.2.18 Radiometer
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.18.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.18.2 Business Overview
-
8.2.18.3 Financials (Subject to data availability)
-
8.2.18.4 Product Types Specification
-
8.2.18.5 Business Strategy
-
8.2.18.6 S.W.O.TAnalysis
-
-
8.2.19 IDEXX Laboratories
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.19.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.19.2 Business Overview
-
8.2.19.3 Financials (Subject to data availability)
-
8.2.19.4 Product Types Specification
-
8.2.19.5 Business Strategy
-
8.2.19.6 S.W.O.TAnalysis
-
-
8.2.20 Siemens
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.20.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.20.2 Business Overview
-
8.2.20.3 Financials (Subject to data availability)
-
8.2.20.4 Product Types Specification
-
8.2.20.5 Business Strategy
-
8.2.20.6 S.W.O.TAnalysis
-
-
8.2.21 Fujirebio
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.21.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.21.2 Business Overview
-
8.2.21.3 Financials (Subject to data availability)
-
8.2.21.4 Product Types Specification
-
8.2.21.5 Business Strategy
-
8.2.21.6 S.W.O.TAnalysis
-
-
8.2.22 Autobio Diagnostics Co
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.22.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.22.2 Business Overview
-
8.2.22.3 Financials (Subject to data availability)
-
8.2.22.4 Product Types Specification
-
8.2.22.5 Business Strategy
-
8.2.22.6 S.W.O.TAnalysis
-
-
8.2.23 BioLegend
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.23.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.23.2 Business Overview
-
8.2.23.3 Financials (Subject to data availability)
-
8.2.23.4 Product Types Specification
-
8.2.23.5 Business Strategy
-
8.2.23.6 S.W.O.TAnalysis
-
-
8.2.24 Guangzhou Wondfo Biotech
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.24.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.24.2 Business Overview
-
8.2.24.3 Financials (Subject to data availability)
-
8.2.24.4 Product Types Specification
-
8.2.24.5 Business Strategy
-
8.2.24.6 S.W.O.TAnalysis
-
-
8.2.25 Inova Diagnostics Inc.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.25.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.25.2 Business Overview
-
8.2.25.3 Financials (Subject to data availability)
-
8.2.25.4 Product Types Specification
-
8.2.25.5 Business Strategy
-
8.2.25.6 S.W.O.TAnalysis
-
-
8.2.26 ELISA
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.26.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.26.2 Business Overview
-
8.2.26.3 Financials (Subject to data availability)
-
8.2.26.4 Product Types Specification
-
8.2.26.5 Business Strategy
-
8.2.26.6 S.W.O.TAnalysis
-
-
8.2.27 Danaher Corporation (Beckman Coulter)
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
-
8.2.27.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
-
8.2.27.2 Business Overview
-
8.2.27.3 Financials (Subject to data availability)
-
8.2.27.4 Product Types Specification
-
8.2.27.5 Business Strategy
-
8.2.27.6 S.W.O.TAnalysis
-
-
Chapter 9 Qualitative Analysis (Subject to Data Availability)
-
9.1 Market Drivers
-
9.2 Market Trends
-
9.3 Market Restraints
-
9.4 Market Opportunity
-
9.5 Product Life Cycle (Subject to Data Availability)
-
9.6 Industrial Chain Analysis (Subject to Data Availability)
-
9.6.1 Industry Chain Analysis
-
9.6.2 Manufacturing Cost Analysis
-
9.6.3 Consumer Preference Analysis
-
9.6.4 Supply Side Analysis
-
9.6.4.1 Raw Material Analysis
-
9.6.4.2 Raw Material Procurement Analysis
-
9.6.4.3 Raw Material Price Trend Analysis
-
-
-
9.7 Market Attractiveness Analysis
-
9.8 PESTEL Analysis
-
9.9 Porter’s Five Forces Analysis
-
9.10 Patent Analysis (Subject to Data Availability)
-
9.11 ESG Analysis
-
9.12 Technological Road Map
Segmentation Product Type Analysis 2019 -2031, will provide market size split by Product Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Product Type Analysis 2019 -2031
-
10.1 Reagents & Kits
-
10.1.1 Global Immunoassays Revenue Market Size and Share by Reagents & Kits 2019 -2031
-
-
10.2 Analyzer/ instruments
-
10.2.1 Global Immunoassays Revenue Market Size and Share by Analyzer/ instruments 2019 -2031
-
-
10.3 Software
-
10.3.1 Global Immunoassays Revenue Market Size and Share by Software 2019 -2031
-
-
10.4 Services
-
10.4.1 Global Immunoassays Revenue Market Size and Share by Services 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Analysis 2019 -2031
-
11.1 Cardiology
-
11.1.1 Global Immunoassays Revenue Market Size and Share by Cardiology 2019 - 2031
-
-
11.2 Infectious diseases
-
11.2.1 Global Immunoassays Revenue Market Size and Share by Infectious diseases 2019 - 2031
-
-
11.3 Endocrinology
-
11.3.1 Global Immunoassays Revenue Market Size and Share by Endocrinology 2019 - 2031
-
-
11.4 Hematology
-
11.4.1 Global Immunoassays Revenue Market Size and Share by Hematology 2019 - 2031
-
-
11.5 Oncology
-
11.5.1 Global Immunoassays Revenue Market Size and Share by Oncology 2019 - 2031
-
-
11.6 Toxicology
-
11.6.1 Global Immunoassays Revenue Market Size and Share by Toxicology 2019 - 2031
-
-
11.7 Bone And Mineral Disorders
-
11.7.1 Global Immunoassays Revenue Market Size and Share by Bone And Mineral Disorders 2019 - 2031
-
-
11.8 Blood Screening
-
11.8.1 Global Immunoassays Revenue Market Size and Share by Blood Screening 2019 - 2031
-
-
11.9 Autoimmune Disorders
-
11.9.1 Global Immunoassays Revenue Market Size and Share by Autoimmune Disorders 2019 - 2031
-
-
11.10 Allergy Diagnostics
-
11.10.1 Global Immunoassays Revenue Market Size and Share by Allergy Diagnostics 2019 - 2031
-
-
11.11 Newborn Screening
-
11.11.1 Global Immunoassays Revenue Market Size and Share by Newborn Screening 2019 - 2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Technology Analysis 2019 -2031
-
12.1 Enzyme-Linked Immunosorbent Assay (ELISA)
-
12.1.1 Global Immunoassays Revenue Market Size and Share by Enzyme-Linked Immunosorbent Assay (ELISA) 2019 -2031
-
-
12.2 Chemiluminescence immunoassay
-
12.2.1 Global Immunoassays Revenue Market Size and Share by Chemiluminescence immunoassay 2019 -2031
-
-
12.3 Rapid Tests
-
12.3.1 Global Immunoassays Revenue Market Size and Share by Rapid Tests 2019 -2031
-
-
12.4 Enzyme-Linked Fluorescent Assay (ELFA)
-
12.4.1 Global Immunoassays Revenue Market Size and Share by Enzyme-Linked Fluorescent Assay (ELFA) 2019 -2031
-
-
12.5 ELISpot
-
12.5.1 Global Immunoassays Revenue Market Size and Share by ELISpot 2019 -2031
-
-
12.6 Western Blotting
-
12.6.1 Global Immunoassays Revenue Market Size and Share by Western Blotting 2019 -2031
-
-
12.7 Radioimmunoassay
-
12.7.1 Global Immunoassays Revenue Market Size and Share by Radioimmunoassay 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Specimen Analysis 2019 -2031
-
13.1 Blood
-
13.1.1 Global Immunoassays Revenue Market Size and Share by Blood 2019 -2031
-
-
13.2 Saliva
-
13.2.1 Global Immunoassays Revenue Market Size and Share by Saliva 2019 -2031
-
-
13.3 Urine
-
13.3.1 Global Immunoassays Revenue Market Size and Share by Urine 2019 -2031
-
-
13.4 Other
-
13.4.1 Global Immunoassays Revenue Market Size and Share by Other 2019 -2031
-
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by End User Analysis 2019 -2031
-
14.1 Hospitals
-
14.1.1 Global Immunoassays Revenue Market Size and Share by Hospitals 2019 -2031
-
-
14.2 Clinics
-
14.2.1 Global Immunoassays Revenue Market Size and Share by Clinics 2019 -2031
-
-
14.3 Laboratories
-
14.3.1 Global Immunoassays Revenue Market Size and Share by Laboratories 2019 -2031
-
-
14.4 Pharmaceutical and Biotechnology Companies
-
14.4.1 Global Immunoassays Revenue Market Size and Share by Pharmaceutical and Biotechnology Companies 2019 -2031
-
-
14.5 Blood Banks
-
14.5.1 Global Immunoassays Revenue Market Size and Share by Blood Banks 2019 -2031
-
-
14.6 Academics Research Centers
-
14.6.1 Global Immunoassays Revenue Market Size and Share by Academics Research Centers 2019 -2031
-
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Immunoassays market
Chapter 15 Research Findings
-
15.1 Key Takeaways
-
15.2 Analyst Point of View
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
-
15.3 Assumptions and Acronyms
Sample Format of Deliverables
The Tables, Graphs/Charts are only for representative purposes and do not depict actual statistics. Purchase full Report access to actual data.
Qualitative Analysis
Research Methodology Implemented by Anushka Gore and Team
- 1.1 Immunoassays Market Report 2024 Research Methodology
- 1.2 Systematic Research Approach
- 1.2.1 Primary Research for Immunoassays Market
- 1.2.1.1 Key Data from Primary
- 1.2.1.2 Primary Interviews with Experts
- 1.2.1.3 Key Industry Insights
- 1.2.1.4 Questionnaire for Immunoassays Market
- 1.2.1.5 Breakdown of Primaries
- 1.2.2 Secondary Research for Immunoassays Market
- 1.2.2.1 Key Data from Secondary
- 1.2.2.2 Paid Sources
- 1.2.2.3 Public Sources
- 1.3 Market Size Estimation for Immunoassays Market
- 1.3.1 Top-Down Approach
- 1.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 1.3.2 Bottom-UP Approach
- 1.3.2.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
- 1.3.1 Top-Down Approach
- 1.4 Market Breakdown and Data Triangulation
- 1.5 Research Assumptions for Immunoassays Market
Key Questions Answered By Immunoassays Market Report 2024
| Why Reagents & Kits have a significant impact on Immunoassays market? |
| What are the key factors affecting the Reagents & Kits and Analyzer/ instruments of Immunoassays Market? |
| What is the CAGR/Growth Rate of Cardiology during the forecast period? |
| By type, which segment accounted for largest share of the global Immunoassays Market? |
| Which region is expected to dominate the global Immunoassays Market within the forecast period? |
| Segmentation Level Customization |
|
| Global level Data Customization |
|
| Region level Data Customization |
|
| Country level Data Customization |
|
| Company Level |
|
| Additional Data Analysis |
|
| Additional Qualitative Data |
|
| Additional Quantitative Data |
|
| Service Level Customization |
|
Report Format Alteration |
|
